T1	Participants 115 128	GERD patients
T2	Participants 215 263	gastro-esophageal reflux disease (GERD) patients
T3	Participants 506 644	Forty-seven GERD patients randomized to endoscopic fundoplication (n = 32) or PPI therapy (n = 15), and 29 healthy controls were included.
